Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice?

Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice?

Aim. To determine the blood concentration of fibrosis biomarkers in patients with atrial fibrillation (AF) in combination with metabolic syndrome (MS) and to analyze the relationship with myocardial fibrosis.Material and methods. This cross-sectional case-control study included 547 patients aged 35...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Ionin, E L Zaslavskaya, E I Barashkova, V A Pavlova, G I Borisov, K A Averchenko, A N Morozov, E I Baranova, E V Schlyachto
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2021-08-01
Series:Российский кардиологический журнал
Subjects:
aldosterone
galectin-3
gdf-15
tgf-beta-1
ctgf
pinp
piiinp
atrial fibrillation
metabolic syndrome
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4579
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://russjcardiol.elpub.ru/jour/article/view/4579

Similar Items